MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-06-2026
Canopy Growth Corporation P/S Ratio 2011-2026 | CGC
Annual P/S Ratio Canopy Growth Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.528 | 2.16 | 0.0835 | 0.0494 | 5.94 | 14 K | 0.000006 | 53.3 | 19.9 | 12.4 | 22.4 | - | - | - | - |
All numbers in CAD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 14 K | 0.000006 | 1.28 K |
P/S Ratio of other stocks in the Drug manufacturers industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AcelRx Pharmaceuticals
ACRX
|
18.8 | - | 7.5 % | $ 6.35 M |  USA |
 |
Agile Therapeutics
AGRX
|
0.066 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
1.26 | - | - | $ 142 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
3.78 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
1.68 | - | - | $ 754 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
4.24 | - | - | $ 2.06 B |  France |
 |
China Pharma Holdings
CPHI
|
1 | $ 0.61 | -1.46 % | $ 10.7 M |  China |
 |
Cumberland Pharmaceuticals
CPIX
|
8.49 | $ 3.9 | 1.56 % | $ 54.8 M | USA |
 |
Cronos Group
CRON
|
77.6 | $ 2.74 | 3.6 % | $ 1.43 B |  Canada |
 |
Eagle Pharmaceuticals
EGRX
|
1.07 | - | -39.89 % | $ 27.7 M | USA |
 |
Catalent
CTLT
|
2.48 | - | - | $ 11.5 B | USA |
 |
Evoke Pharma
EVOK
|
0.432 | - | - | $ 36.6 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
6.01 K | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
0.719 | - | 2.45 % | $ 38.1 M | Canada |
 |
DURECT Corporation
DRRX
|
3.72 | - | - | $ 50.1 M | USA |
 |
Emergent BioSolutions
EBS
|
0.132 | $ 10.91 | -0.27 % | $ 559 M | USA |
 |
Harrow Health
HROW
|
2.67 | $ 52.51 | 1.86 % | $ 1.71 B | USA |
 |
Endo International plc
ENDP
|
0.0339 | - | - | $ 28.9 M |  Irlanda |
 |
Athenex
ATNX
|
0.111 | - | -23.39 % | $ 1.76 M | USA |
 |
Evolus
EOLS
|
3.33 | $ 4.3 | -0.69 % | $ 267 M | USA |
 |
OrganiGram Holdings
OGI
|
4.82 | $ 1.44 | 2.5 % | $ 402 M | Canada |
 |
Lannett Company
LCI
|
0.0823 | - | 1.15 % | $ 7.11 M | USA |
 |
Jupiter Wellness
JUPW
|
118 | - | - | $ 33.6 M | USA |
 |
Bausch Health Companies
BHC
|
0.386 | $ 6.04 | 0.83 % | $ 2.2 B | Canada |
 |
Sundial Growers
SNDL
|
0.0158 | $ 1.55 | 4.03 % | $ 3.37 M | Canada |
 |
Neoleukin Therapeutics
NLTX
|
2.11 | - | - | $ 193 M | Canada |
 |
Pacira BioSciences
PCRX
|
5.13 | $ 23.39 | 1.21 % | $ 1.08 B | USA |
 |
Organogenesis Holdings
ORGO
|
0.86 | $ 4.01 | 2.42 % | $ 528 M | USA |
 |
PetIQ
PETQ
|
0.36 | - | 1.64 % | $ 400 M | USA |
 |
Perrigo Company plc
PRGO
|
0.905 | $ 14.63 | 0.48 % | $ 2.01 B | USA |
 |
Aurora Cannabis
ACB
|
3.73 | $ 3.8 | 4.11 % | $ 86.3 M | Canada |
 |
ProPhase Labs
PRPH
|
1.06 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
1.64 | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
1.41 | - | -4.76 % | $ 65.3 M | USA |
 |
Rockwell Medical
RMTI
|
0.424 | $ 0.94 | 1.95 % | $ 21.9 M | USA |
 |
Tilray
TLRY
|
1.9 | $ 7.89 | 4.44 % | $ 4.88 B | Canada |
 |
OptiNose
OPTN
|
2.7 | - | - | $ 1.08 B | USA |
 |
Assertio Holdings
ASRT
|
0.434 | $ 12.04 | - | $ 855 M | USA |
 |
PLx Pharma
PLXP
|
14.4 | - | -27.8 % | $ 2.56 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
0.256 | $ 2.83 | -0.35 % | $ 3.51 M | USA |
 |
SCYNEXIS
SCYX
|
0.502 | $ 0.8 | 3.91 % | $ 38.3 M | USA |
 |
Veru
VERU
|
6.39 | $ 2.63 | 6.05 % | $ 355 M | USA |
 |
TherapeuticsMD
TXMD
|
18.4 | $ 2.25 | -1.32 % | $ 23.5 M | USA |
 |
cbdMD
YCBD
|
0.0863 | $ 0.92 | 0.72 % | $ 3.97 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
895 | - | - | $ 55.5 M | USA |
 |
Viatris
VTRS
|
0.837 | $ 16.15 | 1.22 % | $ 19.6 B | USA |